1. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives
- Author
-
Kazutoshi Mizoue, Kunihiro Kitamura, Wai-Ching Tse, Toshimasa Ishida, Keita Matsumoto, and Carol P. Huber
- Subjects
Models, Molecular ,Stereochemistry ,Protein Conformation ,Static Electricity ,Biophysics ,Succinic Acid ,E-64 ,Cysteine Proteinase Inhibitors ,Crystallography, X-Ray ,Biochemistry ,Cathepsin A ,Cathepsin B ,Cathepsin C ,Biomaterials ,Cathepsin L ,chemistry.chemical_compound ,Structure-Activity Relationship ,Cathepsin O ,Leucine ,Cathepsin ,Binding Sites ,biology ,Organic Chemistry ,General Medicine ,Cysteine protease ,Cysteine Endopeptidases ,chemistry ,Drug Design ,biology.protein ,Epoxy Compounds - Abstract
This paper focuses on the inhibitory mechanism of E-64 and its derivatives (epoxysuccinyl-based inhibitors) with some cysteine proteases, based on the binding modes observed in the x-ray crystal structures of their enzyme-inhibitor complexes. E-64 is a potent irreversible inhibitor against general cysteine proteases, and its binding modes with papain, actinidin, cathepsin L, and cathepsin K have been reviewed at the atomic level. E-64 interacts with the Sn subsites of cysteine proteases. Although the Sn-Pn (n = 1-3) interactions of the inhibitor with the main chains of the active site residues are similar in respective complexes, the significant difference is observed in the side-chain interactions of S2-P2 and S3-P3 pairs because of different residues constituting the respective subsites. E-64-c and CA074 are representative derivatives developed from E-64 as a clinical usable and a cathepsin B-specific inhibitors, respectively. In contrast with similar binding/inhibitory modes of E-64-c and E-64 for cysteine proteases, the inhibitory mechanism of cathepsin B-specific CA074 results from the binding to the Sn' subsite.
- Published
- 1999